An analysis of a 'community-driven' reconstruction of the human metabolic network

Metabolomics

Volumn 9, Issue 4, 2013, Pages 757-764

  Swainston, Neil ^a   Mendes, Pedro ^a,b   Kell, Douglas B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Metabolic networks; Metabolism; Modelling; Networks; Systems biology

Indexed keywords

BIOTECHNOLOGY; MACHINE LEARNING; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; METABOLISM; METABOLOMICS; PREDICTION; REVIEW; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; SEMANTICS;

SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM;

EID: 84880610734     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0564-3     Document Type: Review

References (127)

1. Adams, R., Clark, A., Yamaguchi, A., et al. (2013). SBSI: an extensible distributed software infrastructure for parameter estimation in systems biology. Bioinformatics, 29, 664-665.
2. Agren, R., Liu, L., Shoaie, S., Vongsangnak, W., Nookaew, I., & Nielsen, J. (2013). The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum. PLoS Computational Biology, 9, e1002980.
3. Al-Awqati, Q. (1999). One hundred years of membrane permeability: does overton still rule? Nature Cell Biology, 1, E201-E202.
4. Allen, J. K., Davey, H. M., Broadhurst, D., et al. (2003). High-throughput characterisation of yeast mutants for functional genomics using metabolic footprinting. Nature Biotechnology, 21, 692-696.
5. Ananiadou, S., Kell, D. B., & Tsujii, J. (2006). Text mining and its potential applications in systems biology. Trends in Biotechnology, 24, 571-579.
6. Ananiadou, S., Pyysalo, S., Tsujii, J., & Kell, D. B. (2010). Event extraction for systems biology by text mining the literature. Trends in Biotechnology, 28, 381-390.
7. Attwood, T. K., Kell, D. B., McDermott, P., Marsh, J., Pettifer, S. R., & Thorne, D. (2009). Calling International rescue: knowledge lost in literature and data landslide! Biochemical Journal, 424, 317-333.
8. Attwood, T. K., Kell, D. B., McDermott, P., Marsh, J., Pettifer, S., & Thorne, D. (2010). Utopia documents: linking scholarly literature with research data. Bioinformatics, 26, i568-i574.
9. Becker, J., Zelder, O., Häfner, S., Schröder, H., & Wittmann, C. (2011). From zero to hero-design-based systems metabolic engineering of Corynebacterium glutamicum for l-lysine production. Metabolic Engineering, 13, 159-168.
10. Begley, P., Francis-McIntyre, S., Dunn, W. B., et al. (2009). Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale non-targeted metabolomic studies of human serum. Analytical Chemistry, 81, 7038-7046.
11. Bennett, B. J., Vallim, T. Q., Wang, Z., et al. (2013). Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metabolism, 17, 49-60.
12. Broadhurst, D., & Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171-196.
13. Brown, M., Dunn, W. B., Dobson, P., et al. (2009). Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst, 134, 1322-1332.
14. Burckhardt, G., & Burckhardt, B. C. (2011). In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. Handbook of Experimental Pharmacology, 201, 29-104.
15. Chifman, J., Kniss, A., Neupane, P., et al. (2012). The core control system of intracellular iron homeostasis: a mathematical model. Journal of Theoretical Biology, 300, 91-99.
16. Coles, S. J., Day, N. E., Murray-Rust, P., Rzepa, H. S., & Zhang, Y. (2005). Enhancement of the chemical semantic web through the use of InChI identifiers. Organic & Biomolecular Chemistry, 3, 1832-1834.
17. Collino, S., Martin, F. P., & Rezzi, S. (2013). Clinical metabolomics paves the way towards future healthcare strategies. British Journal of Clinical Pharmacology, 75, 619-629.
18. Courtot, M., Juty, N., Knüpfer, C., et al. (2011). Controlled vocabularies and semantics in systems biology. Molecular Systems Biology, 7, 543.
19. Dada, J. O., Spasic, I., Paton, N. W., & Mendes, P. (2010). SBRML: a markup language for associating systems biology data with models. Bioinformatics, 26, 932-938.
20. DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012). Drug transporters in drug efficacy and toxicity. Annual Review of Pharmacology and Toxicology, 52, 249-273.
21. Dobson, P. D., & Kell, D. B. (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nature Reviews Drug Discovery, 7, 205-220.
22. Dobson, P. D., Lanthaler, K., Oliver, S. G., & Kell, D. B. (2009a). Implications of the dominant role of transporters in drug uptake by cells. Current Topics in Medicinal Chemistry, 9, 163-184.
23. Dobson, P. D., Patel, Y., & Kell, D. B. (2009b). "Metabolite-likeness" as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discovery Today, 14, 31-40.
24. Dobson, P. D., Smallbone, K., Jameson, D., et al. (2010). Further developments towards a genome-scale metabolic model of yeast. BMC Systems Biology, 4, 145.
25. Duarte, N. C., Becker, S. A., Jamshidi, N., et al. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proceedings of the National Academy of Sciences USA, 104, 1777-1782.
26. Empfield, J. R., & Leeson, P. D. (2010). Lessons learned from candidate drug attrition. IDrugs, 13, 869-873.
27. Frezza, C., Zheng, L., Folger, O., et al. (2011). Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature, 477, 225-228.
28. Funke, C., Schneider, S. A., Berg, D., & Kell, D. B. (2013). Genetics and iron in the systems biology of Parkinson's disease and some related disorders. Neurochemistry International, 62, 637-652.
29. Gasteiger, J. (Ed.). (2003). Handbook of chemoinformatics: from data to knowledge. Weinheim: Wiley-VCH.
30. Giacomini, K. M., Huang, S. M., Tweedie, D. J., et al. (2010). Membrane transporters in drug development. Nature Reviews Drug Discovery, 9, 215-236.
31. Gille, C., Bölling, C., Hoppe, A., et al. (2010). HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Molecular Systems Biology, 6, 411.
32. Goodacre, R. (2007). Metabolomics of a superorganism. Journal of Nutrition, 137, 259S-266S.
33. Guo, A. C., Jewison, T., Wilson, M., et al. (2013). ECMDB: the E. coli Metabolome Database. Nucleic Acids Research, 41, D625-D630.
34. Hakenberg, J., Schmeier, S., Kowald, A., Klipp, E., & Leser, U. (2004). Finding kinetic parameters using text mining. OMICS: A Journal of Integrative Biology, 8, 131-152.
35. Hastings, J., de Matos, P., Dekker, A., et al. (2013). The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013. Nucleic Acids Research, 41, D456-D463.
36. Haug, K., Salek, R. M., Conesa, P., et al. (2013). MetaboLights-an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Research, 41, D781-D786.
37. Heavner, B. D., Smallbone, K., Barker, B., Mendes, P., & Walker, L. P. (2012). Yeast 5-an expanded reconstruction of the Saccharomyces cerevisiae metabolic network. BMC Systems Biology, 6, 55.
38. Heinken, A., Sahoo, S., Fleming, R. M., & Thiele, I. (2013). Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microbes, 4, 28-40.
39. Henry, C. S., DeJongh, M., Best, A. A., Frybarger, P. M., Linsay, B., & Stevens, R. L. (2010). High-throughput generation, optimization and analysis of genome-scale metabolic models. Nature Biotechnology, 28, 977-982.
40. Herrgård, M. J., Swainston, N., Dobson, P., et al. (2008). A consensus yeast metabolic network obtained from a community approach to systems biology. Nature Biotechnology, 26, 1155-1160.
41. Hood, L., & Flores, M. (2012). A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New Biotechnology, 15, 613-624.
42. Hopkins, A. L. (2008). Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology, 4, 682-690.
43. Hopkins, A. L. (2009). Predicting promiscuity. Nature, 462, 167-168.
44. Hower, V., Mendes, P., Torti, F. M., et al. (2009). A general map of iron metabolism and tissue-specific subnetworks. Molecular BioSystems, 5, 422-443.
45. Hucka, M., Finney, A., Bornstein, B. J., et al. (2004). Evolving a lingua franca and associated software infrastructure for computational systems biology: the systems biology markup language (SBML) project. Systematic Biology, 1, 41-53.
46. Hucka, M., Finney, A., Sauro, H. M., et al. (2003). The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics, 19, 524-531.
47. Hyduke, D. R., Lewis, N. E., & Palsson, B. Ø. (2013). Analysis of omics data with genome-scale models of metabolism. Molecular BioSystems, 9, 167-174.
48. Jerby, L., Shlomi, T., & Ruppin, E. (2010). Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Molecular Systems Biology, 6, 401.
49. Kamp, H., Strauss, V., Wiemer, J., et al. (2012). Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies. Toxicology Letters, 215, 143-149.
50. Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 28, 27-30.
51. Kell, D. B. (2006a). Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor Bücher lecture. FEBS Journal, 273, 873-894.
52. Kell, D. B. (2006b). Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discovery Today, 11, 1085-1092.
53. Kell, D. B. (2009). Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Medical Genomics, 2, 2.
54. Kell, D. B. (2010). Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology, 577, 825-889.
55. Kell, D. B. (2011). Metabolites do social networking. Nature Chemical Biology, 7, 7-8.
56. Kell, D. B., Brown, M., Davey, H. M., Dunn, W. B., Spasic, I., & Oliver, S. G. (2005). Metabolic footprinting and systems biology: the medium is the message. Nature Reviews Microbiology, 3, 557-565.
57. Kell, D. B., Darby, R. M., & Draper, J. (2001). Genomic computing: explanatory analysis of plant expression profiling data using machine learning. Plant Physiology, 126, 943-951.
58. Kell, D. B., & Dobson, P. D. (2009). The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology. In M. G. Hicks & C. Kettner (Eds.), Proc Int Beilstein Symposium on Systems Chemistry (pp. 149-168). Berlin: Logos Verlag.
59. Kell, D. B., Dobson, P. D., Bilsland, E., & Oliver, S. G. (2013). The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discovery Today, 18, 218-239.
60. Kell, D. B., Dobson, P. D., & Oliver, S. G. (2011). Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discovery Today, 16, 704-714.
61. Kell, D. B., Goodacre, R. (2013). Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discovery Today. (Submitted).
62. Kell, D. B., & Mendes, P. (2008). The markup is the model: reasoning about systems biology models in the semantic web era. Journal of Theoretical Biology, 252, 538-543.
63. Kildegaard, H. F., Baycin-Hizal, D., Lewis, N. E., Betenbaugh, M. J. (2013). The emerging CHO systems biology era: harnessing the 'omics revolution for biotechnology. Current Opinion in Biotechnology, doi: 10. 1016/j. copbio. 2013. 02. 007. (Epub ahead of print).
64. King, R. D., Garrett, S. M., & Coghill, G. M. (2005). On the use of qualitative reasoning to simulate and identify metabolic pathways. Bioinformatics, 21, 2017-2026.
65. Knox, C., Shrivastava, S., Sothard, P., Eisner, R., & Wishart, D. S. (2007). Biospider: a web server for automating metabolome annotations. Pacific Symposium on Biocomputing, 12, 145-156.
66. Kola, I. (2008). The state of innovation in drug development. Clinical Pharmacology and Therapeutics, 83, 227-230.
67. Kola, I., & Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery, 3, 711-715.
68. Krause, F., Schulz, M., Swainston, N., & Liebermeister, W. (2011). Sustainable model building the role of standards and biological semantics. Methods in Enzymology, 500, 371-395.
69. Kwong, E., Higgins, J., & Templeton, A. C. (2011). Strategies for bringing drug delivery tools into discovery. International Journal of Pharmaceutics, 412, 1-7.
70. Lanthaler, K., Bilsland, E., Dobson, P., et al. (2011). Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast. BMC Biology, 9, 70.
71. Le Novère, N., Finney, A., Hucka, M., et al. (2005). Minimum information requested in the annotation of biochemical models (MIRIAM). Nature Biotechnology, 23, 1509-1515.
72. Lee, J. W., Na, D., Park, J. M., Lee, J., Choi, S., & Lee, S. Y. (2012a). Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nature Chemical Biology, 8, 536-546.
73. Lee, D., Smallbone, K., Dunn, W. B., et al. (2012b). Improving metabolic flux predictions using absolute gene expression data. BMC Systems Biology, 6, 73.
74. Leeson, P. D., & Empfield, J. R. (2010). Reducing the risk of drug attrition associated with physicochemical properties. Annual Reports in Medicinal Chemistry, 45, 393-407.
75. Levandi, T., Leon, C., Kaljurand, M., Garcia-Cañas, V., & Cifuentes, A. (2008). Capillary electrophoresis time-of-flight mass spectrometry for comparative metabolomics of transgenic versus conventional maize. Analytical Chemistry, 80, 6329-6335.
76. Li, P., Dada, J. O., Jameson, D., et al. (2010a). Systematic integration of experimental data and models in systems biology. BMC Bioinformatics, 11, 582.
77. Li, X., Gianoulis, T. A., Yip, K. Y., Gerstein, M., & Snyder, M. (2010b). Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses. Cell, 143, 639-650.
78. Li, L., Li, R., Zhou, J., Zuniga, A., et al. (2013). MyCompoundID: using an Evidence-based Metabolome Library for Metabolite Identification. Analytical Chemistry, 85, 3401-3408.
79. Li, P., Oinn, T., Soiland, S., & Kell, D. B. (2008a). Automated manipulation of systems biology models using libSBML within Taverna workflows. Bioinformatics, 24, 287-289.
80. Li, X., & Snyder, M. (2011). Metabolites as global regulators: a new view of protein regulation: systematic investigation of metabolite-protein interactions may help bridge the gap between genome-wide association studies and small molecule screening studies. BioEssays, 33, 485-489.
81. Li, M., Wang, B., Zhang, M., et al. (2008b). Symbiotic gut microbes modulate human metabolic phenotypes. Proceedings of the National Academy of Sciences USA, 105, 2117-2122.
82. Liebermeister, W., & Klipp, E. (2006). Bringing metabolic networks to life: convenience rate law and thermodynamic constraints. Theoretical Biology and Medical Model, 3, 41.
83. Ma, H., Sorokin, A., Mazein, A., et al. (2007). The Edinburgh human metabolic network reconstruction and its functional analysis. Molecular Systems Biology, 3, 135.
84. Mendes, P., & Kell, D. B. (1998). Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics, 14, 869-883.
85. Miwa, M., Ohta, T., Rak, R., et al. (2013). A method for integrating and ranking the evidence for biochemical pathways by mining reactions from text. Bioinformatics. (In press).
86. Miwa, M., Thompson, P., McNaught, J., Kell, D. B., & Ananiadou, S. (2012). Extracting semantically enriched events from biomedical literature. BMC Bioinformatics, 13, 108.
87. Mo, M. L., Palsson, B. O., & Herrgård, M. J. (2009). Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Systems Biology, 3, 37.
88. Moles, C. G., Mendes, P., & Banga, J. R. (2003). Parameter estimation in biochemical pathways: a comparison of global optimization methods. Genome Research, 13, 2467-2474.
89. Nobata, C., Dobson, P., Iqbal, S. A., et al. (2011). Mining metabolites: extracting the yeast metabolome from the literature. Metabolomics, 7, 94-101.
90. O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open babel: an open chemical toolbox. Journal of Cheminformatics, 3, 33.
91. O'Hagan, S., Dunn, W. B., Broadhurst, D., et al. (2007). Closed-loop, multi-objective optimisation of two-dimensional gas chromatography (GCxGC-tof-MS) for serum metabolomics. Analytical Chemistry, 79, 464-476.
92. O'Hagan, S., Dunn, W. B., Brown, M., Knowles, J. D., & Kell, D. B. (2005). Closed-loop, multiobjective optimisation of analytical instrumentation: gas-chromatography-time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. Analytical Chemistry, 77, 290-303.
93. Orth, J. D., Thiele, I., & Palsson, B. Ø. (2010). What is flux balance analysis? Nature Biotechnology, 28, 245-248.
94. Palsson, B. Ø. (2006). Systems biology: properties of reconstructed networks. Cambridge: Cambridge University Press.
95. Park, J. M., Kim, T. Y., & Lee, S. Y. (2010). Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses. Proceedings of the National Academy of Sciences USA, 107, 14931-14936.
96. Park, J. H., Lee, K. H., Kim, T. Y., & Lee, S. Y. (2007). Metabolic engineering of Escherichia coli for the production of l-valine based on transcriptome analysis and in silico gene knockout simulation. Proceedings of the National Academy of Sciences USA, 104, 7797-7802.
97. Raamsdonk, L. M., Teusink, B., Broadhurst, D., et al. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnology, 19, 45-50.
98. Ray, O., Whelan, K., & King, R. (2010). Automatic revision of metabolic networks through logical analysis of experimental data. Inductive Logic Programming, 5989, 194-201.
99. Reed, J. L., & Palsson, B. Ø. (2003). Thirteen years of building constraint-based in silico models of Escherichia coli. Journal of Bacteriology, 185, 2692-2699.
100. Sakurai, N., Ara, T., Kanaya, S., et al. (2013). An application of a relational database system for high-throughput prediction of elemental compositions from accurate mass values. Bioinformatics, 29, 290-291.
101. Salek, R. M., Haug, K., Conesa, P., et al. (2013). The MetaboLights repository: curation challenges in metabolomics. Database, 2013, bat029.
102. Sawada, Y., Nakabayashi, R., Yamada, Y., et al. (2012). RIKEN tandem mass spectral database (ReSpect) for phytochemicals: a plant-specific MS/MS-based data resource and database. Phytochemistry, 82, 38-45.
103. Shlomi, T., Cabili, M. N., & Ruppin, E. (2009). Predicting metabolic biomarkers of human inborn errors of metabolism. Molecular Systems Biology, 5, 263.
104. Sigurdsson, M. I., Jamshidi, N., Steingrimsson, E., Thiele, I., & Palsson, B. Ø. (2010). A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Systems Biology, 4, 140.
105. Smallbone, K., & Simeonidis, E. (2008). Flux balance analysis: a geometric perspective. Journal of Theoretical Biology, 258, 311-315.
106. Smallbone, K., Simeonidis, E., Broomhead, D. S., & Kell, D. B. (2007). Something from nothing: bridging the gap between constraint-based and kinetic modelling. FEBS Journal, 274, 5576-5585.
107. Smallbone, K., Simeonidis, E., Swainston, N., & Mendes, P. (2010). Towards a genome-scale kinetic model of cellular metabolism. BMC Systems Biology, 4, 6.
108. Steinbeck, C., Conesa, P., Haug, K., et al. (2012). MetaboLights: towards a new COSMOS of metabolomics data management. Metabolomics, 8, 757-760.
109. Steinbeck, C., Han, Y., Kuhn, S., Horlacher, O., Luttmann, E., & Willighagen, E. (2003). The Chemistry Development Kit (CDK): an open-source Java library for Chemo-and Bioinformatics. Journal of Chemical Information and Computer Sciences, 43, 493-500.
110. Swainston, N., & Mendes, P. (2009). libAnnotationSBML: a library for exploiting SBML annotations. Bioinformatics, 25, 2292-2293.
111. Swainston, N., Smallbone, K., Mendes, P., Kell, D., & Paton, N. (2011). The SuBliMinaL toolbox: automating steps in the reconstruction of metabolic networks. Journal of Integrative Bioinformatics, 8, 186.
112. Tautenhahn, R., Cho, K., Uritboonthai, W., Zhu, Z. J., Patti, G. J., & Siuzdak, G. (2012). An accelerated workflow for untargeted metabolomics using the METLIN database. Nature Biotechnology, 30, 826-828.
113. Thiele, I., Hyduke, D. R., Steeb, B., et al. (2011). A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella typhimurium LT2. BMC Systems Biology, 5, 8.
114. Thiele, I., & Palsson, B. Ø. (2010). Reconstruction annotation jamborees: a community approach to systems biology. Molecular Systems Biology, 6, 361.
115. Thiele, I., Swainston, N., Fleming, R. M. T., et al. (2013). A community-driven global reconstruction of human metabolism. Nature Biotechnology, 31, 419-425.
116. Uhlén, M., Oksvold, P., Fagerberg, L., et al. (2010). Towards a knowledge-based Human Protein Atlas. Nature Biotechnology, 28, 1248-1250.
117. van der Greef, J., & McBurney, R. N. (2005). Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nature Reviews Drug Discovery, 4, 961-967.
118. van Ravenzwaay, B., Herold, M., Kamp, H., et al. (2012). Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. Mutation Research, 746, 144-150.
119. Wang, Y., Eddy, J. A., & Price, N. D. (2012). Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Systems Biology, 6, 153.
120. Wang, Z., Klipfell, E., Bennett, B. J., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472, 57-63.
121. Wikoff, W. R., Anfora, A. T., Liu, J., et al. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences USA, 106, 3698-3703.
122. Wishart, D. S. (2012). Chapter 3: small molecules and disease. PLoS Computational Biology, 8, e1002805.
123. Wishart, D. S., Jewison, T., Guo, A. C., et al. (2013). HMDB 3. 0-The Human Metabolome Database in 2013. Nucleic Acids Research, 41, D801-D807.
124. Wishart, D. S., Tzur, D., Knox, C., et al. (2007). HMDB: the Human Metabolome Database. Nucleic Acids Research, 35, D521-D526.
125. Zelena, E., Dunn, W. B., Broadhurst, D., et al. (2009). Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Analytical Chemistry, 81, 1357-1364.
126. Zhao, L., & Shen, J. (2010). Whole-body systems approaches for gut microbiota-targeted, preventive healthcare. Journal of Biotechnology, 149, 183-190.
127. Zhou, B., Wang, J., & Ressom, H. W. (2012). MetaboSearch: tool for mass-based metabolite identification using multiple databases. PLoS One, 7, e40096.